Cloud computing In Pharmaceutical Market Report 2026

Cloud computing In Pharmaceutical Market Overview

• Cloud computing In Pharmaceutical market size has reached to $12.93 billion in 2025 • Expected to grow to $27.60 billion in 2030 at a compound annual growth rate (CAGR) of 16.3% • Growth Driver: Rising Demand For Personalized Medicine Fueling The Growth Of The Market Due To Advancements In Genomic Technologies And Tailored Patient Care • Market Trend: Strengthening Cloud Computing In Pharmaceuticals With Centralized Security, Unified IT Control, And Scalable Scientific Workflows • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cloud computing In Pharmaceutical Market?

Cloud computing in pharmaceutical refers to the delivery of on-demand computing resources, data storage, analytics tools, and digital platforms that support pharmaceutical research, drug development, manufacturing, supply chain operations, and commercial activities. These cloud-based systems enable real-time data access, scalable computing, enhanced collaboration, and improved regulatory compliance while reducing IT infrastructure costs. By integrating advanced technologies such as big data analytics, artificial intelligence, and machine learning, cloud computing enhances efficiency, accelerates innovation, and supports decision-making across the pharmaceutical value chain. The main service models of cloud computing in pharmaceutical include infrastructure as a service (IaaS), platform as a service (PaaS), and software as a service (SaaS). IaaS refers to cloud-based computing infrastructure that provides scalable storage, servers, and networking resources. The deployment types include public cloud, private cloud, and hybrid cloud solutions. The technology types include artificial intelligence (AI) and machine learning, big data analytics, internet of things (IoT), blockchain, and data backup and disaster recovery solutions. The applications include drug discovery and development, clinical trials management, manufacturing and supply chain operations, regulatory compliance, and pharmacovigilance, catering to key end users such as pharmaceutical companies, biotechnology firms, research organizations, contract research organizations (CROs), and academic institutions.

What Is The Cloud computing In Pharmaceutical Market Growth Forecast?

The cloud computing in pharmaceutical market size is expected to see rapid growth in the next few years. It will grow to $27.60 billion in 2030 at a compound annual growth rate (CAGR) of 16.3%. The growth in the forecast period can be attributed to growing demand for AI-enabled drug discovery, rising adoption of hybrid cloud models, increasing shift toward digital pharma manufacturing, expansion of real-world data and analytics usage, and growing need for secure cloud-based compliance systems. Major trends in the forecast period include advancements in AI and machine learning platforms, developments in cloud-based clinical trial technologies, innovations in blockchain-enabled data security, research and development in automated pharmaceutical workflows, and advancements in big data analytics for drug development.

Global Cloud computing In Pharmaceutical Market Segmentation

1) By Service Model: Infrastructure As A Service (IaaS), Platform As A Service (PaaS), Software As A Service (SaaS) 2) By Deployment Type: Public Cloud, Private Cloud, Hybrid Cloud 3) By Technology Type: Artificial Intelligence (AI) And Machine Learning, Big Data Analytics, Internet Of Things (IoT), Blockchain, Data Backup And Disaster Recovery Solutions 4) By Application Area: Drug Discovery And Development, Clinical Trials Management, Manufacturing And Supply Chain, Regulatory Compliance, Pharmacovigilance 5) By End User: Pharmaceutical Companies, Biotechnology Firms, Research Organizations, Contract Research Organizations (CROs), Academic Institutions Subsegments: 1) By Infrastructure As A Service: Virtual Machines, Storage Services, Networking Services, Backup Services, Disaster Recovery 2) By Platform As A Service: Application Hosting, Database Management, Development Tools, Middleware Services, Integration Services 3) By Software As A Service: Clinical Data Management Software, Regulatory Compliance Software, Supply Chain Management Software, Collaboration Tools, Analytics Software

What Is The Driver Of The Cloud computing In Pharmaceutical Market?

The rising demand for personalized medicine is expected to propel the growth of the cloud computing in pharmaceutical market going forward. Personalized medicine is a medical approach that involves tailoring treatments to individual patients based on their genetic, environmental, and lifestyle factors to optimize outcomes and improve care. The demand for personalized medicine is increasing due to advancements in genomic technologies, which enable the precise identification of genetic variations and tailored treatments for individuals. Cloud computing in pharmaceutical enhances personalized medicine by enabling scalable storage and processing of large volumes of patient, genomic, and clinical data. It improves treatment accuracy and development speed by supporting advanced analytics, real-time collaboration, and data-driven drug discovery tailored to individual patient profiles. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. Therefore, the rising demand for personalized medicine is driving the growth of the cloud computing in pharmaceutical industry.

Key Players In The Global Cloud computing In Pharmaceutical Market

Major companies operating in the cloud computing in pharmaceutical market are Amazon Web Services Inc., Google LLC, Microsoft Corporation, Alibaba Group Holding Ltd., Dell Technologies Inc., Tencent Holdings Ltd., Accenture plc, International Business Machines Corporation, Cisco Systems Inc., Oracle Corporation, Salesforce Inc., SAP SE, Hewlett Packard Enterprise Company, Capgemini SE, Cognizant Technology Solutions Corporation, DXC Technology Company, Akamai Technologies Inc., Snowflake Inc., CareCloud Inc., ClearDATA Networks Inc.

Global Cloud computing In Pharmaceutical Market Trends and Insights

Major companies operating in the cloud computing in pharmaceutical market are focusing on developing advanced platforms, such as unifying platforms, to improve data protection, regulatory compliance, and operational efficiency across scientific software platforms. A unifying platform refers to a single, integrated system that brings together multiple tools, functions, or services into one cohesive interface. For instance, in April 2024, Certara Inc., a US-based provider of model-informed drug development software, launched Certara Cloud. This unifying platform integrates the company's extensive suite of scientific software solutions, allowing customers to access and manage their licensed products from discovery to submission, using a single login ID, thus enhancing user experience and accelerating time-to-insight for novel therapeutic programs. a cloud platform to further unify its end-to-end scientific software ecosystem, featuring centralized security and IT administration. By embedding centralized security controls into its cloud platform, Certara enhances data integrity, simplifies regulatory compliance, and supports secure collaboration across the drug development lifecycle, from early research through regulatory submission.

What Are Latest Mergers And Acquisitions In The Cloud computing In Pharmaceutical Market?

In April 2024, Bayer AG, a Germany-based life sciences and pharmaceutical company, partnered with Google Cloud to develop generative AI-powered healthcare applications focused on radiology. Through this partnership, Bayer utilizes Google Cloud’s advanced artificial intelligence tools, including Vertex AI, to build an innovation platform that assists radiologists in analyzing vast amounts of medical imaging data. Google Cloud is a US-based technology company providing cloud computing services and machine learning platforms.

Regional Insights

North America was the largest region in the cloud computing in pharmaceutical market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cloud computing In Pharmaceutical Market?

The cloud computing in pharmaceutical market includes revenues earned by entities through cloud-based data management platforms, software-as-a-service (SaaS) solutions, infrastructure-as-a-service (IaaS), platform-as-a-service (PaaS), clinical data storage services, cybersecurity services, digital supply chain solutions, and cloud-hosted research and development tools. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cloud computing In Pharmaceutical Market Report 2026?

The cloud computing in pharmaceutical market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cloud computing in pharmaceutical industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.